ArticleSchizophrenia (Heidelberg, Germany)2023
Influence of psychopathology and metabolic parameters on quality of life in patients with first-episode psychosis before and after initial antipsychotic treatment.
Anne Sofie A Dahl, Victor Sørensen, Karen S Ambrosen, Mikkel E Sørensen, Grímur H Mohr, Mette Ø Nielsen, Kirsten B Bojesen, Birte Y Glenthøj, Margaret Hahn, Julie Midtgaard and 1 more
Abstract read
In one paragraphArticle in Schizophrenia (Heidelberg, Germany), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from itWhat it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
11 authors.
Anne Sofie A DahlCenter for Clinical Intervention and Neuropsychiatric Schizophrenia Research (CINS) & Center for Neuropsychiatric Schizophrenia Research (CNSR), Copenhagen University Hospital-Mental Health Services Copenhagen, Copenhagen, Denmark.
Karen S AmbrosenCenter for Clinical Intervention and Neuropsychiatric Schizophrenia Research (CINS) & Center for Neuropsychiatric Schizophrenia Research (CNSR), Copenhagen University Hospital-Mental Health Services Copenhagen, Copenhagen, Denmark.ORCID http://orcid.org/0000-0002-5638-2357 Mikkel E SørensenCenter for Clinical Intervention and Neuropsychiatric Schizophrenia Research (CINS) & Center for Neuropsychiatric Schizophrenia Research (CNSR), Copenhagen University Hospital-Mental Health Services Copenhagen, Copenhagen, Denmark.
Grímur H MohrCenter for Clinical Intervention and Neuropsychiatric Schizophrenia Research (CINS) & Center for Neuropsychiatric Schizophrenia Research (CNSR), Copenhagen University Hospital-Mental Health Services Copenhagen, Copenhagen, Denmark.
Mette Ø NielsenCenter for Clinical Intervention and Neuropsychiatric Schizophrenia Research (CINS) & Center for Neuropsychiatric Schizophrenia Research (CNSR), Copenhagen University Hospital-Mental Health Services Copenhagen, Copenhagen, Denmark.
Kirsten B BojesenCenter for Clinical Intervention and Neuropsychiatric Schizophrenia Research (CINS) & Center for Neuropsychiatric Schizophrenia Research (CNSR), Copenhagen University Hospital-Mental Health Services Copenhagen, Copenhagen, Denmark.ORCID http://orcid.org/0000-0002-7996-3154 Birte Y GlenthøjCenter for Clinical Intervention and Neuropsychiatric Schizophrenia Research (CINS) & Center for Neuropsychiatric Schizophrenia Research (CNSR), Copenhagen University Hospital-Mental Health Services Copenhagen, Copenhagen, Denmark.ORCID http://orcid.org/0000-0003-3056-7262 Bjørn H EbdrupCenter for Clinical Intervention and Neuropsychiatric Schizophrenia Research (CINS) & Center for Neuropsychiatric Schizophrenia Research (CNSR), Copenhagen University Hospital-Mental Health Services Copenhagen, Copenhagen, Denmark. bjoern.ebdrup@regionh.dk.
Funding
Lundbeckfonden (Lundbeck Foundation) R377-2021-340
6 · The paper itselfAbstract
The impact of psychological and physical health on quality of life (QoL) in patients with early psychosis remain relatively unexplored. We evaluated the predictive value of psychopathological and metabolic parameters on QoL in antipsychotic-naïve patients with first-episode psychosis before and after initial antipsychotic treatment. At baseline, 125 patients underwent assessments of psychopathology, prevalence of metabolic syndrome (MetS), and QoL. After 6 weeks of antipsychotic monotherapy, 89 patients were re-investigated. At baseline, the prevalence of MetS was 19.3% (n = 22). After 6 weeks, body weight (1.3 kg, p < 0.001) and body mass index (0.4 kg/m
Identifiers
PMID37935717
PMCPMC10630335
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390